Cryo-Cell International, Inc. is a cord blood bank. It was founded by Dan Richard in 1989. Cryo-Cell International is the first private cord blood bank to separate and store stem cells. Cryo-Cell is headquartered outside of Tampa, in Oldsmar, Florida. In January 1997, the Company's stock began trading on the NASDAQ Small Cap market under symbol CCEL.
| trading_symbol | registrant_name | time | price | change | percentage_change |
|---|---|---|---|---|---|
| CCEL | CRYO CELL INTERNATIONAL INC | 2026-03-03 11:50:26 | 3.26 | -0.02 | -0.61 |
| trading_symbol | central_index_key | registrant_name | isin_number | lei_number | ein_number | exchange | sic_code | sic_description | fiscal_year_end | state_of_incorporation | address_street | address_city | address_state | address_zip_code | address_country | address_country_code | phone_number | mailing_address | business_address | former_name | industry | founding_date | chief_executive_officer | number_of_employees | website | market_cap | shares_issued | shares_outstanding | description | update_time |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CCEL | 0000862692 | CRYO CELL INTERNATIONAL INC | US2288951088 | 254900AQWFD6AR2J7Z30 | 223023093 | NYSE | 8090 | Services-Misc Health & Allied Services, NEC | 1130 | DE | 700 BROOKER CREEK BLVD | OLDSMAR | FL | 34677 | UNITED STATES | US | 813-749-2104 | 700 BROOKER CREEK BLVD, OLDSMAR, FL, 34677 | 700 BROOKER CREEK BLVD, OLDSMAR, FL, 34677 | CRYO CELL INTERNATIONAL INC | — | 1989 | — | — | http://cryo-cell.com | 43,849,869 | 14,877,119 | 8,055,150 | Cryo-Cell International, Inc. is a cord blood bank. It was founded by Dan Richard in 1989. Cryo-Cell International is the first private cord blood bank to separate and store stem cells. Cryo-Cell is headquartered outside of Tampa, in Oldsmar, Florida. In January 1997, the Company's stock began trading on the NASDAQ Small Cap market under symbol CCEL. | 2026-02-26 21:01:38 |
| Fiscal Year | Market Cap | Change In Market Cap | Percentage Change In Market Cap | Shares Outstanding | Change In Shares Outstanding | Percentage Change In Shares Outstanding |
|---|---|---|---|---|---|---|
| 2024 | 43,849,869 | 16,839,443 | 62.3442 | 8,082,159 | -204,626 | -2.4693 |
| 2023 | 27,010,426 | -8,438,665 | -23.805 | 8,286,785 | -156,531 | -1.8539 |
| 2022 | 35,449,091 | -12,158,104 | -25.5384 | 8,443,316 | -59,302 | -0.6975 |
| Executive Name | Executive Position | Fiscal Year | Salary | Bonus | Stock Awards | Incentive Plan Compensation | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Oleg Mikulinsky | Chief Information Officer | 2024 | 329,889 | 63,000 | 0 | — | — | 430,950 |
| Mark Portnoy | Co-Chief Executive Officer | 2024 | 556,687 | 450,000 | 0 | — | — | 1,211,713 |
| David Portnoy | Co-Chief Executive Officer | 2024 | 721,632 | 750,000 | 0 | — | — | 1,884,353 |
| Jill Taymans | Chief Financial Officer, Vice President | 2024 | 280,000 | 20,000 | 0 | — | — | 322,931 |
| David Portnoy | Co-Chief Executive Officer | 2023 | 700,000 | 750,000 | 0 | — | — | 1,869,397 |
| Fiscal Year | Employee Count |
|---|---|
| 2025 | 72 |
| 2024 | 82 |
| 2023 | 82 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Revenue | 31,566,321 | 31,986,106 | 31,343,695 |
| Cost Of Revenue | 7,376,648 | 7,947,752 | 8,442,310 |
| Gross Profit | — | — | — |
| Research And Development Expenses | 376,263 | 1,242,536 | 1,171,456 |
| General And Administrative Expenses | 18,220,708 | 18,521,218 | 17,115,514 |
| Operating Expenses | 31,083,927 | 28,505,822 | 43,647,727 |
| Operating Income | 482,394 | 3,480,284 | -12,304,032 |
| Net Income | -2,429,385 | 402,095 | -9,521,669 |
| Earnings Per Share Basic | -0.3 | 0.05 | -1.14 |
| Earnings Per Share Diluted | -0.3 | 0.05 | -1.14 |
| Weighted Average Shares Outstanding Basic | 8,068,777 | 8,130,676 | 8,340,839 |
| Weighted Average Shares Outstanding Diluted | 8,068,777 | 8,212,510 | 8,340,839 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Cash And Cash Equivalents | 319,031 | 560,960 | 406,067 |
| Marketable Securities Current | 2,977,013 | 2,935,183 | 574,183 |
| Accounts Receivable | 6,846,180 | 7,309,094 | 6,576,240 |
| Inventories | 408,794 | 657,703 | 768,877 |
| Non Trade Receivables | — | — | — |
| Other Assets Current | 633,985 | 454,598 | 389,950 |
| Total Assets Current | 11,758,221 | 12,554,593 | 9,452,837 |
| Marketable Securities Non Current | — | — | — |
| Property Plant And Equipment | 21,034,372 | 21,894,263 | 20,996,883 |
| Other Assets Non Current | 28,935,921 | 30,228,777 | 30,771,050 |
| Total Assets Non Current | 49,970,293 | 52,123,040 | 51,767,933 |
| Total Assets | 61,728,514 | 64,677,633 | 61,220,770 |
| Accounts Payable | 2,870,771 | 1,882,274 | 3,174,584 |
| Deferred Revenue | 9,730,318 | 9,788,574 | 9,704,553 |
| Short Term Debt | 2,300,000 | 3,520,000 | 1,222,728 |
| Other Liabilities Current | 4,278,027 | 5,809,872 | 5,170,809 |
| Total Liabilities Current | 19,792,987 | 21,599,542 | 20,864,001 |
| Long Term Debt | 8,353,780 | 8,480,533 | 8,595,678 |
| Other Liabilities Non Current | 60,541,456 | 56,294,108 | 51,388,001 |
| Total Liabilities Non Current | 60,541,456 | 56,294,108 | 51,388,001 |
| Total Liabilities | 80,334,443 | 77,893,650 | 72,252,002 |
| Common Stock | 148,771 | 148,696 | 148,492 |
| Retained Earnings | -38,438,238 | -32,777,626 | -31,159,182 |
| Accumulated Other Comprehensive Income | — | — | — |
| Total Shareholders Equity | -18,605,929 | -13,216,017 | -11,031,232 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Depreciation And Amortization | 751,474 | 483,522 | 1,124,228 |
| Share Based Compensation Expense | 417,101 | 781,128 | 816,639 |
| Other Non Cash Income Expense | -48,304 | — | 0 |
| Change In Accounts Receivable | 405,881 | 1,999,759 | 1,568,689 |
| Change In Inventories | -56,190 | -429,178 | -360,445 |
| Change In Non Trade Receivables | — | — | — |
| Change In Other Assets | — | — | — |
| Change In Accounts Payable | 1,000,257 | -423,720 | 688,935 |
| Change In Other Liabilities | 0 | 639,063 | 1,582,135 |
| Cash From Operating Activities | 5,478,606 | 6,010,910 | 8,919,754 |
| Purchases Of Marketable Securities | — | — | — |
| Sales Of Marketable Securities | 2,787,907 | 1,516,359 | 397,831 |
| Acquisition Of Property Plant And Equipment | 230,475 | 2,403,708 | 6,838,969 |
| Acquisition Of Business | — | — | — |
| Other Investing Activities | — | — | — |
| Cash From Investing Activities | -975,332 | -4,876,899 | -8,144,754 |
| Tax Withholding For Share Based Compensation | — | — | — |
| Payments Of Dividends | 3,231,227 | 2,020,539 | — |
| Issuance Of Common Stock | — | — | — |
| Repurchase Of Common Stock | 169,502 | 1,423,871 | 799,036 |
| Issuance Of Long Term Debt | — | — | — |
| Repayment Of Long Term Debt | 10,020,000 | 2,922,728 | 2,000,000 |
| Other Financing Activities | — | — | — |
| Cash From Financing Activities | -4,745,203 | -979,118 | -2,072,891 |
| Change In Cash | -241,929 | 154,893 | -1,297,891 |
| Cash At End Of Period | 319,031 | 560,960 | 406,067 |
| Income Taxes Paid | 4,594,638 | 2,716,993 | 1,820,802 |
| Interest Paid | 2,029,012 | 1,976,808 | 1,808,751 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Earnings Per Share | -0.3 | 0.05 | -1.14 |
| Price To Earnings Ratio | -13.2667 | 173.4 | -4.693 |
| Earnings Growth Rate | -700 | -104.386 | -445.4545 |
| Price Earnings To Growth Ratio | 0.019 | -1.6611 | 0.0105 |
| Book Value Per Share | -2.3059 | -1.6255 | -1.3226 |
| Price To Book Ratio | -1.726 | -5.3339 | -4.0452 |
| Ebitda | 4,982,983 | 5,467,294 | -5,339,845 |
| Enterprise Value | 42,448,481.46 | 81,932,533.92 | 54,035,827.65 |
| Dividend Yield | 0.1006 | 0.0287 | — |
| Dividend Payout Ratio | -1.3301 | 5.025 | — |
| Debt To Equity Ratio | -0.5726 | -0.908 | -0.8901 |
| Capital Expenditures | -108,417 | 1,380,902 | 8,517,996 |
| Free Cash Flow | 5,587,023 | 4,630,008 | 401,758 |
| Return On Equity | 0.1306 | -0.0304 | 0.8632 |
| One Year Beta | 0.1825 | -0.0073 | 0.2545 |
| Three Year Beta | 0.1748 | 0.0907 | 0.0808 |
| Five Year Beta | 0.1054 | 0.1707 | 0.1583 |
| Insider Name | Relationship To Issuer | Transaction Date | Amount Of Securities | Acquired Or Disposed | Securities Owned Following Transaction |
|---|---|---|---|---|---|
| TAYMANS JILL M | VP Finance, CFO | 2026-01-07 | 10,000 | A | 10,000 |
| TAYMANS JILL M | VP Finance, CFO | 2026-01-07 | 20,000 | A | 20,000 |
| Portnoy Mark L. | Director, Co-CEO, 10% owner | 2026-01-07 | 50,000 | A | 50,000 |
| Portnoy Mark L. | Director, Co-CEO, 10% owner | 2026-01-07 | 25,000 | A | 25,000 |
| Mikulinsky Oleg | Chief Information Officer | 2026-01-07 | 10,000 | A | 10,000 |
| Investor Name | Period Of Report | Market Value | Amount Of Securities | Price Per Security |
|---|---|---|---|---|
| CITADEL ADVISORS LLC | 2025-12-31 | 49,965 | 14,525 | 3.4399 |
| BANK OF AMERICA CORP /DE/ | 2025-12-31 | 10 | 3 | 3.3333 |
| NORTHERN TRUST CORP | 2025-12-31 | 98,780 | 28,716 | 3.4399 |
| OSAIC HOLDINGS, INC. | 2025-12-31 | 8,600 | 2,500 | 3.44 |
| Tower Research Capital LLC (TRC) | 2025-12-31 | 4,204 | 1,222 | 3.4403 |
| Registrant Name | Period Of Report | Fund Name | Fund Symbol | Amount Of Units | Value In Usd | Percentage Value Compared To Assets |
|---|---|---|---|---|---|---|
| VANGUARD INDEX FUNDS | 2025-12-31 | Institutional Select Shares | VSTSX | 94,688 | 325,717.25 | 0.0 |
| VANGUARD INDEX FUNDS | 2025-12-31 | Institutional Plus Shares | VSMPX | 94,688 | 325,717.25 | 0.0 |
| VANGUARD INDEX FUNDS | 2025-12-31 | ETF Shares | VTI | 94,688 | 325,717.25 | 0.0 |
| VANGUARD INDEX FUNDS | 2025-12-31 | Institutional Shares | VITSX | 94,688 | 325,717.25 | 0.0 |
| VANGUARD INDEX FUNDS | 2025-12-31 | Admiral Shares | VTSAX | 94,688 | 325,717.25 | 0.0 |